Search

Sep 18 // OECD

Taliaz CEO, Dekel Taliaz, invited to join as a panel member of the OECD workshop Shanghai, China

September 2018 //

The panel titled “Minding Neurotechnology: delivering responsible innovation for health and well-being” on the 6-7th September will will explore the unique ethical, legal, and policy challenges raised by health-related applications of brainscience and its integration into cutting edge neurotechnologies.



Read article >





CONTACT US

Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

office@taliazhealth.com

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook
PREDICTIX_Logo_Dark.png

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved